BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10086964)

  • 1. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure.
    Loh E; Rebbeck TR; Mahoney PD; DeNofrio D; Swain JL; Holmes EW
    Circulation; 1999 Mar; 99(11):1422-5. PubMed ID: 10086964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adenosine monophosphate deaminase-1 gene polymorphism in patients with congestive heart failure (influence on tumor necrosis factor-alpha level and outcome).
    Gastmann A; Sigusch HH; Henke A; Reinhardt D; Surber R; Gastmann O; Figulla HR
    Am J Cardiol; 2004 May; 93(10):1260-4. PubMed ID: 15135700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression.
    Feldman AM; Wagner DR; McNamara DM
    Circulation; 1999 Mar; 99(11):1397-9. PubMed ID: 10086958
    [No Abstract]   [Full Text] [Related]  

  • 4. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease.
    Anderson JL; Habashi J; Carlquist JF; Muhlestein JB; Horne BD; Bair TL; Pearson RR; Hart N
    J Am Coll Cardiol; 2000 Oct; 36(4):1248-52. PubMed ID: 11028479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of AMPD1 C34T genotype as a predictor of mortality in heart failure and post-myocardial infarction patients.
    Collins RP; Palmer BR; Pilbrow AP; Frampton CM; Troughton RW; Yandle TG; Skelton L; Richards AM; Cameron VA
    Am Heart J; 2006 Aug; 152(2):312-20. PubMed ID: 16875916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPD1 (C34T) polymorphism and clinical outcomes in patients undergoing myocardial revascularization.
    Andreassi MG; Botto N; Laghi-Pasini F; Manfredi S; Ghelarducci B; Farneti A; Solinas M; Biagini A; Picano E
    Int J Cardiol; 2005 May; 101(2):191-5. PubMed ID: 15882662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.
    Taegtmeyer AB; Breen JB; Rogers P; Johnson PH; Smith J; Smolenski RT; Banner NR; Yacoub MH; Barton PJ
    Am J Cardiol; 2009 May; 103(10):1457-62. PubMed ID: 19427446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failure.
    Kolek MJ; Carlquist JF; Thaneemit-Chen S; Lazzeroni LC; Whiting BM; Horne BD; Muhlestein JB; Lavori P; Anderson JL
    J Card Fail; 2005 Dec; 11(9):677-83. PubMed ID: 16360962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.
    Gross M; Rötzer E; Kölle P; Mortier W; Reichmann H; Goebel HH; Lochmüller H; Pongratz D; Mahnke-Zizelman DK; Sabina RL
    Neuromuscul Disord; 2002 Aug; 12(6):558-65. PubMed ID: 12117480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
    Kalsi KK; Yuen AH; Rybakowska IM; Johnson PH; Slominska E; Birks EJ; Kaletha K; Yacoub MH; Smolenski RT
    Cardiovasc Res; 2003 Sep; 59(3):678-84. PubMed ID: 14499869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPD1 gene mutations are associated with obesity and diabetes in Polish patients with cardiovascular diseases.
    Safranow K; Suchy J; Jakubowska K; Olszewska M; Bińczak-Kuleta A; Kurzawski G; Rzeuski R; Czyżycka E; Łoniewska B; Kornacewicz-Jach Z; Ciechanowicz A; Chlubek D
    J Appl Genet; 2011 Feb; 52(1):67-76. PubMed ID: 21108053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of C34T AMPD1 gene polymorphism with features of metabolic syndrome in patients with coronary artery disease or heart failure.
    Safranow K; Czyzycka E; Binczak-Kuleta A; Rzeuski R; Skowronek J; Wojtarowicz A; Jakubowska K; Olszewska M; Loniewska B; Kaliszczak R; Kornacewicz-Jach Z; Ciechanowicz A; Chlubek D
    Scand J Clin Lab Invest; 2009; 69(1):102-12. PubMed ID: 18855224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between plasma norepinephrine and response to medical therapy in men with congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy.
    Kao W; Gheorghiade M; Hall V; Goldstein S
    Am J Cardiol; 1989 Sep; 64(10):609-13. PubMed ID: 2782251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the AMPD1 gene polymorphism on exercise capacity, other prognostic parameters, and survival in patients with stable congestive heart failure: a study in 686 consecutive patients.
    de Groote P; Lamblin N; Helbecque N; Mouquet F; Hermant X; Amouyel P; Dallongeville J; Bauters C
    Am Heart J; 2006 Oct; 152(4):736-41. PubMed ID: 16996850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of improved cardiac function in donors with C34T mutation of the AMP deaminase 1 gene.
    Yuen AH; Yacoub MH; Birks EJ; Kalsi KK; Johnson PH; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):275-7. PubMed ID: 16021915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPD1 rs17602729 is associated with physical performance of sprint and power in elite Lithuanian athletes.
    Ginevičienė V; Jakaitienė A; Pranculis A; Milašius K; Tubelis L; Utkus A
    BMC Genet; 2014 May; 15():58. PubMed ID: 24885427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA sequence polymorphism within the bovine adenosine monophosphate deaminase 1 (AMPD1) is associated with production traits in Chinese cattle.
    Wei CB; Wang JQ; Chen FY; Niu H; Li K
    Genet Mol Res; 2015 Feb; 14(1):1025-33. PubMed ID: 25730042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common variant of the AMPD1 gene predicts improved survival in patients with ischemic left ventricular dysfunction.
    Yazaki Y; Muhlestein JB; Carlquist JF; Bair TL; Horne BD; Renlund DG; Anderson JL
    J Card Fail; 2004 Aug; 10(4):316-20. PubMed ID: 15309698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPD1 C34T mutation selectively affects AMP-deaminase activity in the human heart.
    Kalsi KK; Yuen AH; Johnson PH; Birks EJ; Yacoub MH; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(4):287-8. PubMed ID: 16021918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPD1 gene polymorphism and survival in patients with stable congestive heart failure.
    Palmer BR; Frampton CM; Richards AM; Cameron VA
    Am Heart J; 2007 May; 153(5):e13. PubMed ID: 17452134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.